Free Trial
→ Trump set to Boost Social Security Checks by 400%? (From InvestorPlace) (Ad) Free CRH Stock Alerts

CRH (CRH) Financials

CRH logo
$97.83 -0.39 (-0.39%)
As of 03:40 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for CRH

Annual Income Statements for CRH

This table shows CRH's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 685 1,280 2,240 2,889 - 1,304 2,630 3,862 3,178 3,492
Consolidated Net Income / (Loss)		 792 1,336 2,305 2,889 1,738 1,165 2,686 3,889 3,072 3,521
Net Income / (Loss) Continuing Operations		 700 1,251 2,010 1,526 - 1,009 2,507 2,699 3,072 3,521
Total Pre-Tax Income 		1,000 1,704 2,024 1,993 - 1,454 3,102 3,461 4,014 4,714
Total Operating Income		 1,267 2,007 2,315 2,446 - 2,026 3,327 3,809 4,186 4,925
Total Gross Profit		 7,240 8,651 8,863 9,058 9,273 8,565 9,827 10,815 11,963 12,701
Total Revenue		 23,259 26,078 26,011 27,424 - 25,888 29,206 32,723 34,949 35,572
Operating Revenue		 23,259 26,078 26,011 27,424 - 25,888 29,206 32,723 34,949 35,572
Total Cost of Revenue		 16,019 17,427 17,148 18,391 - 17,323 19,379 21,908 22,986 22,871
Operating Cost of Revenue		 16,019 17,427 17,148 18,391 - 17,323 19,379 21,908 22,986 22,871
Total Operating Expenses		 5,973 6,643 6,548 6,612 - 6,539 6,500 7,006 7,777 7,776
Selling, General & Admin Expense		 - - - - - - 6,538 7,056 7,486 7,852
Impairment Charge		 - - - - - - 0.00 0.00 357 161
Other Special Charges / (Income)		 - - - - - - -38 -50 -66 -237
Total Other Income / (Expense), net		 -375 -359 -356 -453 - -589 -225 -348 -172 -211
Interest Expense		 431 411 362 - - 438 315 344 376 612
Interest & Investment Income		 8.69 8.42 14 - - 0.00 0.00 65 206 143
Other Income / (Expense), net		 48 44 -8.41 -453 - -151 90 -69 -2.00 258
Income Tax Expense		 300 453 14 467 - 445 650 762 925 1,085
Other Gains / (Losses), net		 - - - - - - 55 0.00 -17 -108
Net Income / (Loss) Discontinued Operations		 92 85 296 1,388 - 312 179 1,190 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - - - - 56 27 -106 29
Basic Earnings per Share		 $0.89 $1.50 $2.72 - - $1.43 $3.35 $5.15 $4.36 $5.06
Weighted Average Basic Shares Outstanding		 - - 838.96M 843.39M 799.64M 795.14M 780.20M 758.30M 723.90M 683.30M
Diluted Earnings per Share		 $0.89 $1.49 $2.71 - - $1.42 $3.32 $5.11 $4.33 $5.02
Weighted Average Diluted Shares Outstanding		 - - 838.96M 843.39M 799.64M 795.14M 786.80M 764.10M 729.20M 689.50M
Weighted Average Basic & Diluted Shares Outstanding		 - - 838.96M 843.39M 799.64M 795.14M 774.14M 752.14M 690.36M 676.48M
Cash Dividends to Common per Share		 - - - - - - $1.21 $1.27 $1.33 $1.40

Quarterly Income Statements for CRH

This table shows CRH's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -28 1,199 1,306 701 116 1,297 1,376 703 -94
Consolidated Net Income / (Loss)		 -31 1,212 1,318 573 114 1,309 1,389 709 -98
Net Income / (Loss) Continuing Operations		 -31 1,212 1,318 573 114 1,309 1,389 709 -98
Total Pre-Tax Income 		-39 1,578 1,720 755 99 1,733 1,895 987 -146
Total Operating Income		 2.00 1,613 1,788 783 28 1,829 1,964 1,104 18
Total Gross Profit		 1,619 3,630 3,763 2,951 1,807 3,675 4,059 3,160 1,837
Total Revenue		 6,427 9,709 10,128 8,685 6,533 9,654 10,515 8,870 6,756
Operating Revenue		 6,427 9,709 10,128 8,685 6,533 9,654 10,515 8,870 6,756
Total Cost of Revenue		 4,808 6,079 6,365 5,734 4,726 5,979 6,456 5,710 4,919
Operating Cost of Revenue		 4,808 6,079 6,365 5,734 4,726 5,979 6,456 5,710 4,919
Total Operating Expenses		 1,617 2,017 1,975 2,168 1,779 1,846 2,095 2,056 1,819
Selling, General & Admin Expense		 1,622 2,035 1,990 1,839 1,787 1,948 2,184 1,933 1,833
Other Special Charges / (Income)		 -5.00 -18 -15 -28 -8.00 -102 -89 -38 -14
Total Other Income / (Expense), net		 -41 -35 -68 -28 71 -96 -69 -117 -164
Interest Expense		 81 73 131 91 133 155 164 160 181
Interest & Investment Income		 40 36 62 68 43 36 33 31 37
Other Income / (Expense), net		 0.00 2.00 1.00 -5.00 161 23 62 12 -20
Income Tax Expense		 -14 379 416 144 -19 430 531 143 -58
Other Gains / (Losses), net		 -6.00 13 14 -38 -4.00 6.00 25 -135 -10
Net Income / (Loss) Attributable to Noncontrolling Interest		 -3.00 13 12 -128 -2.00 12 13 6.00 -4.00
Basic Earnings per Share		 ($0.05) $1.63 $1.81 $0.97 $0.16 $1.89 $1.99 $1.02 ($0.15)
Weighted Average Basic Shares Outstanding		 742.90M 734.70M 718.20M 723.90M 687.80M 685.50M 681.60M 683.30M 676.70M
Diluted Earnings per Share		 ($0.05) $1.62 $1.80 $0.96 $0.16 $1.88 $1.97 $1.01 ($0.15)
Weighted Average Diluted Shares Outstanding		 742.90M 738.20M 722.10M 729.20M 693.40M 688.80M 685.50M 689.50M 676.70M
Weighted Average Basic & Diluted Shares Outstanding		 - - - 690.36M 686.68M 682.78M 679.34M 676.48M 676.00M
Cash Dividends to Common per Share		 $1.03 $0.00 $0.25 - $0.35 $0.35 $0.35 - $0.37

Annual Cash Flow Statements for CRH

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -4,181 -4,133 -5,388 -5,946 1,552 3,466 -1,938 153 454 -2,631
Net Cash From Operating Activities		 1,057 -1,510 -2,392 -3,885 3,881 4,116 3,979 3,800 5,017 4,989
Net Cash From Continuing Operating Activities		 1,057 -1,510 -2,392 -3,885 2,580 4,116 3,979 3,800 5,017 4,989
Net Income / (Loss) Continuing Operations		 0.00 0.00 0.00 0.00 2,181 1,165 2,686 3,889 3,072 3,521
Consolidated Net Income / (Loss)		 - - - - 2,181 1,165 2,686 3,889 3,072 3,521
Depreciation Expense		 916 1,061 1,208 1,265 1,721 1,624 1,551 1,577 1,633 1,798
Non-Cash Adjustments To Reconcile Net Income		 205 -2,511 -3,285 -4,539 -1,024 1,185 27 -1,242 547 -14
Changes in Operating Assets and Liabilities, net		 -64 -60 -315 -611 -364 142 -285 -424 -235 -316
Net Cash From Investing Activities		 -8,886 -1,054 -3,466 -5,400 217 -1,347 -2,513 -917 -2,391 -6,291
Net Cash From Continuing Investing Activities		 -8,886 -1,054 -3,466 -5,400 -2,040 -1,347 -2,513 -917 -2,397 -6,291
Purchase of Property, Plant & Equipment		 - - -1,254 -1,324 -1,374 -996 -1,554 -1,523 -1,817 -2,578
Acquisitions		 - - -2,211 -4,076 -727 -351 -1,494 -3,253 -640 -4,900
Purchase of Investments		 - - - - - - 0.00 -11 -1.00 -9.00
Sale of Property, Plant & Equipment		 -958 -897 - - - - 387 115 104 272
Divestitures		 -7,927 -157 - - - - 120 3,712 0.00 1,001
Sale and/or Maturity of Investments		 - - - - 39 - 32 36 44 44
Other Investing Activities, net		 - - - - 22 - -4.00 7.00 -87 -121
Net Cash From Financing Activities		 3,648 -1,570 470 3,339 2,546 697 -3,107 -2,499 -2,380 -1,186
Net Cash From Continuing Financing Activities		 3,648 -1,570 470 3,339 -2,485 697 -3,107 -2,499 -2,378 -1,186
Repayment of Debt		 -41 0.00 -434 -291 -996 -4,943 -1,183 -364 -1,462 -1,859
Repurchase of Common Equity		 - - -3.60 -921 -954 -249 -896 -1,178 -3,067 -1,482
Payment of Dividends		 -416 -379 -573 -633 -663 -722 -946 -943 -975 -1,740
Issuance of Debt		 4,105 -1,191 1,480 5,184 106 6,611 0.00 38 3,163 4,001
Other Financing Activities, net		 - - - - 22 - -82 -52 -37 -106
Effect of Exchange Rate Changes		 - - - - - - -297 -231 208 -143
Cash Interest Paid		 328 364 381 394 - 432 340 329 418 599
Cash Income Taxes Paid		 - - - - - - 642 1,043 959 960

Quarterly Cash Flow Statements for CRH

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 -1,286 -375 1,447 668 -3,081 637 -866 679 -407
Net Cash From Operating Activities		 -671 1,634 1,631 2,423 -712 1,485 1,486 2,730 -659
Net Cash From Continuing Operating Activities		 -671 1,634 1,631 2,423 -712 1,485 1,486 2,730 -659
Net Income / (Loss) Continuing Operations		 -31 1,212 1,318 573 114 1,309 1,389 709 -98
Consolidated Net Income / (Loss)		 -31 1,212 1,318 573 114 1,309 1,389 709 -98
Depreciation Expense		 384 401 402 446 397 424 467 510 477
Non-Cash Adjustments To Reconcile Net Income		 36 44 16 451 -105 -80 -155 326 16
Changes in Operating Assets and Liabilities, net		 -1,060 -23 -105 953 -1,118 -168 -215 1,185 -1,054
Net Cash From Investing Activities		 -492 -478 -759 -662 -2,096 -521 -1,788 -1,886 -964
Net Cash From Continuing Investing Activities		 -492 -478 -759 -668 -2,096 -521 -1,788 -1,886 -964
Purchase of Property, Plant & Equipment		 -332 -439 -404 -642 -506 -624 -505 -943 -645
Acquisitions		 -155 -43 -363 -79 -2,206 -316 -1,331 -1,047 -585
Purchase of Investments		 -2.00 9.00 -4.00 -4.00 -13 10 -18 12 20
Sale of Property, Plant & Equipment		 6.00 36 22 40 739 357 84 -908 35
Divestitures		 - - 5.00 -5.00 - - 27 919 36
Sale and/or Maturity of Investments		 8.00 4.00 11 21 6.00 9.00 7.00 22 9.00
Other Investing Activities, net		 -17 -45 -26 1.00 -116 -12 -52 59 166
Net Cash From Financing Activities		 -191 -1,555 649 -1,283 -176 -339 -629 -42 1,141
Net Cash From Continuing Financing Activities		 -191 -1,555 649 -1,281 -176 -339 -629 -42 1,141
Repayment of Debt		 0.00 -849 -91 -522 -651 -1,040 -163 -5.00 -1,533
Repurchase of Common Equity		 -246 -713 -1,072 -1,036 -559 -348 -317 -258 -310
Payment of Dividends		 -13 -771 -12 -179 -767 -486 -249 -238 -17
Issuance of Debt		 71 784 1,832 476 1,818 1,552 82 549 3,017
Other Financing Activities, net		 -3.00 -6.00 -8.00 -20 -17 -17 18 -90 -16
Effect of Exchange Rate Changes		 68 24 -74 190 -97 12 65 -123 75
Cash Interest Paid		 54 147 43 174 45 171 156 227 63
Cash Income Taxes Paid		 104 173 343 339 159 145 350 306 134

Annual Balance Sheets for CRH

This table presents CRH's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 33,237 37,999 46,777 47,612 44,944 44,670 45,319 47,469 50,613
Total Current Assets		 9,882 11,737 17,395 17,258 14,977 14,044 14,833 16,885 14,083
Cash & Equivalents		 2,576 2,541 9,191 9,918 7,721 5,783 5,936 6,341 3,720
Restricted Cash		 - - - - - - - 0.00 39
Accounts Receivable		 4,186 4,361 4,665 4,231 4,086 4,569 4,300 4,507 4,820
Inventories, net		 3,092 3,261 3,505 3,080 3,117 3,611 4,194 4,291 4,755
Other Current Assets		 - - - - - - 403 478 749
Other Current Nonoperating Assets		 - - - - - - - 1,268 0.00
Plant, Property, & Equipment, net		 13,350 15,729 18,046 19,574 19,317 19,502 17,768 17,841 21,452
Total Noncurrent Assets		 10,005 10,533 11,336 10,780 10,650 11,124 12,718 12,743 15,078
Long-Term Investments		 1,367 1,499 1,332 775 626 653 649 620 737
Goodwill		 - - - - - - 9,199 9,158 11,061
Intangible Assets		 8,165 8,666 9,656 9,475 9,373 9,848 1,088 1,041 1,211
Other Noncurrent Operating Assets		 83 66 60 98 197 275 1,782 1,924 2,069
Total Liabilities & Shareholders' Equity		 33,237 37,999 46,777 47,612 44,944 44,670 45,319 47,469 50,613
Total Liabilities		 18,043 20,008 27,825 27,977 24,596 23,756 22,279 25,848 27,763
Total Current Liabilities		 6,690 7,516 14,006 13,411 7,465 7,581 8,041 10,013 10,296
Short-Term Debt		 289 380 7,213 6,616 1,257 549 1,491 1,866 2,999
Accounts Payable		 5,550 5,718 5,817 5,461 5,503 6,409 2,930 3,149 3,207
Accrued Expenses		 - - - - - - 2,132 2,296 2,248
Other Current Liabilities		 436 869 468 769 797 790 1,488 2,327 1,842
Other Current Nonoperating Liabilities		 - - - - - - 0.00 375 0.00
Total Noncurrent Liabilities		 11,353 12,492 13,819 14,566 17,131 16,175 14,238 15,835 17,467
Long-Term Debt		 7,906 9,202 9,959 9,211 10,958 9,938 8,145 9,776 10,969
Noncurrent Deferred & Payable Income Tax Liabilities		 2,112 2,001 2,530 2,627 2,613 2,734 2,885 2,738 3,105
Other Noncurrent Operating Liabilities		 713 836 844 855 954 937 3,208 3,321 3,393
Commitments & Contingencies		 - - - - - - 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 - - - - - - 308 333 384
Total Equity & Noncontrolling Interests		 15,193 17,990 18,951 19,634 20,347 20,914 22,732 21,288 22,466
Total Preferred & Common Equity		 14,616 17,406 18,349 19,027 40,004 20,233 22,157 20,854 21,607
Preferred Stock		 - - - - 7,493 - 1.00 1.00 1.00
Total Common Equity		 14,616 17,406 18,349 19,027 12,162 20,232 22,156 20,853 21,606
Common Stock		 299 344 352 335 333 309 745 750 712
Retained Earnings		 6,809 9,493 11,705 11,350 11,565 19,770 22,495 22,918 24,036
Treasury Stock		 -15 -18 -920 -360 -386 -195 -297 -2,199 -2,137
Accumulated Other Comprehensive Income / (Loss)		 - - - - - - -787 -616 -1,005
Noncontrolling Interest		 576 584 602 607 692 681 575 434 859

Quarterly Balance Sheets for CRH

This table presents CRH's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 45,107 46,142 47,631 46,333 48,105 51,221 51,921
Total Current Assets		 14,230 15,074 16,315 13,709 15,113 14,840 14,242
Cash & Equivalents		 4,650 4,275 5,722 3,308 3,066 2,978 3,352
Restricted Cash		 - 0.00 0.00 - 869 102 0.00
Accounts Receivable		 4,706 6,119 5,972 4,798 5,893 6,422 5,141
Inventories, net		 4,458 4,276 4,191 4,619 4,514 4,644 4,960
Other Current Assets		 416 404 430 748 704 694 789
Other Current Nonoperating Assets		 0.00 0.00 0.00 236 67 0.00 0.00
Plant, Property, & Equipment, net		 17,997 18,155 18,103 18,878 19,235 21,289 22,179
Total Noncurrent Assets		 12,880 12,913 13,213 13,746 13,757 15,092 15,500
Long-Term Investments		 655 672 665 609 484 929 732
Goodwill		 9,308 9,338 9,545 10,125 10,251 10,906 11,475
Intangible Assets		 1,094 1,061 1,074 1,093 1,086 1,105 1,208
Other Noncurrent Operating Assets		 1,823 1,842 1,929 1,919 1,936 2,152 2,085
Total Liabilities & Shareholders' Equity		 45,107 46,142 47,631 46,333 48,105 51,221 51,921
Total Liabilities		 22,963 23,433 24,983 25,591 26,654 28,055 29,564
Total Current Liabilities		 9,255 9,671 9,191 9,997 10,548 10,668 8,712
Short-Term Debt		 2,251 2,185 1,860 2,992 3,218 3,218 1,458
Accounts Payable		 2,627 3,553 2,954 2,730 3,363 2,963 2,777
Accrued Expenses		 2,079 2,335 2,457 2,241 2,272 2,513 2,270
Other Current Liabilities		 2,298 1,598 1,920 1,990 1,681 1,974 2,207
Other Current Nonoperating Liabilities		 0.00 0.00 0.00 44 14 0.00 0.00
Total Noncurrent Liabilities		 13,708 13,762 15,792 15,594 16,106 17,387 20,852
Long-Term Debt		 7,583 7,563 9,535 9,680 9,900 10,672 14,213
Noncurrent Deferred & Payable Income Tax Liabilities		 2,972 3,010 3,050 2,684 2,914 3,168 3,141
Other Noncurrent Operating Liabilities		 3,153 3,189 3,207 3,230 3,292 3,547 3,498
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 307 313 320 326 335 361 379
Total Equity & Noncontrolling Interests		 21,837 22,396 22,328 20,416 21,116 22,805 21,978
Total Preferred & Common Equity		 21,255 21,821 21,767 20,015 20,726 21,875 21,119
Preferred Stock		 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Total Common Equity		 21,254 21,820 21,766 20,014 20,725 21,874 21,118
Common Stock		 722 693 725 631 651 683 587
Retained Earnings		 21,692 22,892 23,936 22,346 23,030 23,831 23,375
Treasury Stock		 -487 -1,140 -2,132 -2,166 -2,143 -2,141 -2,038
Accumulated Other Comprehensive Income / (Loss)		 -673 -625 -763 -797 -813 -499 -806
Noncontrolling Interest		 582 575 561 401 390 930 859

Annual Metrics And Ratios for CRH

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 0.00% 12.12% -0.26% 5.43% 0.00% 0.00% 12.82% 12.04% 6.80% 1.78%
EBITDA Growth		 0.00% 39.55% 12.91% -9.14% -45.15% 95.80% 41.98% 7.03% 9.40% 20.01%
EBIT Growth		 0.00% 56.03% 12.43% -16.16% -100.00% 0.00% 82.24% 9.45% 11.87% 23.88%
NOPAT Growth		 0.00% 66.12% 56.01% -18.51% -100.00% 0.00% 87.05% 12.95% 8.45% 17.70%
Net Income Growth		 0.00% 68.67% 72.54% 25.33% -39.84% -32.97% 130.56% 44.79% -21.01% 14.62%
EPS Growth		 0.00% 68.09% 81.60% 0.00% 0.00% 0.00% 133.80% 53.92% -15.26% 15.94%
Operating Cash Flow Growth		 0.00% -242.79% -58.43% -62.44% 199.90% 6.06% -3.33% -4.50% 32.03% -0.56%
Free Cash Flow Firm Growth		 0.00% 0.00% 97.57% -257.21% 63.29% 454.28% -7.67% 70.22% 22.77% -179.97%
Invested Capital Growth		 0.00% 0.00% 14.08% 15.47% 2.23% -2.36% 2.98% -0.79% -2.61% 27.21%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.52%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.11%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.98%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 8.69%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.02%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.01%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.56%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -2.19%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 31.13% 33.17% 34.07% 33.03% 0.00% 33.08% 33.65% 33.05% 34.23% 35.71%
EBITDA Margin		 9.59% 11.94% 13.51% 11.88% 0.00% 13.52% 17.01% 16.25% 16.64% 19.63%
Operating Margin		 5.45% 7.70% 8.90% 8.92% 0.00% 7.83% 11.39% 11.64% 11.98% 13.85%
EBIT Margin		 5.65% 7.87% 8.87% 7.27% 0.00% 7.24% 11.70% 11.43% 11.97% 14.57%
Profit (Net Income) Margin		 3.41% 5.12% 8.86% 10.53% 0.00% 4.50% 9.20% 11.88% 8.79% 9.90%
Tax Burden Percent		 79.24% 78.40% 113.89% 144.96% 0.00% 80.12% 86.59% 112.37% 76.53% 74.69%
Interest Burden Percent		 76.03% 83.08% 87.76% 100.00% 0.00% 77.55% 90.78% 92.54% 95.94% 90.95%
Effective Tax Rate		 30.00% 26.60% 0.71% 23.43% 0.00% 30.61% 20.95% 22.02% 23.04% 23.02%
Return on Invested Capital (ROIC)		 0.00% 15.17% 11.06% 7.85% 0.00% 5.44% 10.15% 11.34% 12.51% 13.13%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 8.68% 11.22% 26.67% 0.00% 1.33% 11.21% 33.12% 8.14% 9.06%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 2.42% 2.84% 7.80% 0.00% 0.39% 2.87% 6.36% 1.25% 2.70%
Return on Equity (ROE)		 0.00% 17.59% 13.89% 15.64% 9.01% 5.83% 13.02% 17.70% 13.76% 15.84%
Cash Return on Invested Capital (CROIC)		 0.00% -184.83% -2.09% -6.52% -2.21% 7.83% 7.21% 12.14% 15.16% -10.81%
Operating Return on Assets (OROA)		 0.00% 6.17% 6.48% 4.70% 0.00% 4.05% 7.63% 8.31% 9.02% 10.57%
Return on Assets (ROA)		 0.00% 4.02% 6.47% 6.82% 0.00% 2.52% 5.99% 8.64% 6.62% 7.18%
Return on Common Equity (ROCE)		 0.00% 16.92% 13.41% 15.14% 8.73% 4.55% 10.22% 17.07% 13.25% 15.12%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 9.14% 13.24% 15.74% 9.13% 2.91% 13.28% 17.55% 14.73% 16.30%
Net Operating Profit after Tax (NOPAT)		 887 1,473 2,298 1,873 0.00 1,406 2,630 2,970 3,221 3,791
NOPAT Margin		 3.81% 5.65% 8.84% 6.83% 0.00% 5.43% 9.00% 9.08% 9.22% 10.66%
Net Nonoperating Expense Percent (NNEP)		 0.00% 6.49% -0.16% -18.82% -26.43% 4.11% -1.06% -21.78% 4.37% 4.08%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 9.18% 9.78% 10.41%
Cost of Revenue to Revenue		 68.87% 66.83% 65.93% 67.06% 0.00% 66.92% 66.35% 66.95% 65.77% 64.30%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 22.39% 21.56% 21.42% 22.07%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 25.68% 25.48% 25.17% 24.11% 0.00% 25.26% 22.26% 21.41% 22.25% 21.86%
Earnings before Interest and Taxes (EBIT)		 1,315 2,051 2,306 1,993 0.00 1,875 3,417 3,740 4,184 5,183
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2,231 3,113 3,515 3,258 1,787 3,499 4,968 5,317 5,817 6,981
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 1.09 1.65 2.68 2.03 1.30 2.46 2.91
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 2.29 3.29 11.67 3.96 2.43 4.81 6.73
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.73 0.00 1.26 1.41 0.88 1.46 1.77
Price to Earnings (P/E)		 0.00 0.00 0.00 6.90 0.00 24.95 15.65 7.46 16.11 18.00
Dividend Yield		 2.84% 2.38% 2.27% 3.41% 2.15% 2.23% 2.26% 0.00% 1.95% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 14.48% 0.00% 4.01% 6.39% 13.41% 6.21% 5.56%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 1.06 1.48 1.80 1.80 1.25 2.23 2.28
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.99 0.00 1.77 1.62 1.00 1.62 2.07
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 8.34 21.60 13.12 9.51 6.16 9.74 10.54
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 13.64 0.00 24.49 13.82 8.75 13.54 14.19
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 14.51 0.00 32.65 17.96 11.02 17.58 19.40
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 9.95 11.15 11.87 8.62 11.29 14.75
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 22.69 25.28 10.30 14.51 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.54 0.53 0.91 0.88 0.67 0.57 0.42 0.54 0.61
Long-Term Debt to Equity		 0.00 0.52 0.51 0.53 0.54 0.60 0.54 0.35 0.45 0.48
Financial Leverage		 0.00 0.28 0.25 0.29 0.34 0.29 0.26 0.19 0.15 0.30
Leverage Ratio		 0.00 2.19 2.15 2.29 2.45 2.32 2.17 2.05 2.08 2.21
Compound Leverage Factor		 0.00 1.82 1.88 2.29 0.00 1.80 1.97 1.89 1.99 2.01
Debt to Total Capital		 0.00% 35.04% 34.75% 47.54% 46.72% 39.98% 36.19% 29.49% 35.00% 37.94%
Short-Term Debt to Total Capital		 0.00% 1.24% 1.38% 19.97% 17.95% 3.71% 1.68% 4.56% 5.61% 8.15%
Long-Term Debt to Total Capital		 0.00% 33.80% 33.37% 27.57% 28.77% 36.27% 34.51% 24.93% 29.39% 29.79%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 22.10% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 2.46% 2.12% 1.67% 1.65% 2.04% 2.08% 2.70% 2.31% 3.38%
Common Equity to Total Capital		 0.00% 62.50% 63.13% 50.80% 51.63% 35.88% 61.73% 67.81% 62.69% 58.68%
Debt to EBITDA		 0.00 2.63 2.73 5.27 9.64 3.87 2.39 1.81 2.00 2.00
Net Debt to EBITDA		 0.00 1.36 1.56 2.04 3.65 1.48 1.08 0.57 0.80 1.36
Long-Term Debt to EBITDA		 0.00 2.54 2.62 3.06 5.93 3.51 2.28 1.53 1.68 1.57
Debt to NOPAT		 0.00 5.56 4.17 9.17 0.00 9.64 4.51 3.24 3.61 3.68
Net Debt to NOPAT		 0.00 2.87 2.39 3.54 0.00 3.69 2.05 1.03 1.45 2.50
Long-Term Debt to NOPAT		 0.00 5.37 4.00 5.32 0.00 8.75 4.30 2.74 3.03 2.89
Altman Z-Score		 0.00 0.00 0.00 1.59 1.11 2.07 2.74 2.64 3.07 3.15
Noncontrolling Interest Sharing Ratio		 0.00% 3.79% 3.50% 3.21% 3.13% 21.99% 21.49% 3.56% 3.70% 4.52%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 0.00 1.48 1.56 1.24 1.29 2.01 1.85 1.84 1.69 1.37
Quick Ratio		 0.00 1.01 0.92 0.99 1.06 1.58 1.37 1.27 1.08 0.83
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -17,949 -435 -1,555 -571 2,023 1,868 3,179 3,903 -3,122
Operating Cash Flow to CapEx		 110.32% -168.23% -190.71% -293.43% 282.46% 413.25% 340.96% 269.89% 292.88% 216.35%
Free Cash Flow to Firm to Interest Expense		 0.00 -43.64 -1.20 0.00 0.00 4.62 5.93 9.24 10.38 -5.10
Operating Cash Flow to Interest Expense		 2.45 -3.67 -6.61 0.00 0.00 9.40 12.63 11.05 13.34 8.15
Operating Cash Flow Less CapEx to Interest Expense		 0.23 -5.85 -10.08 0.00 0.00 7.12 8.93 6.95 8.79 4.38
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.78 0.73 0.65 0.00 0.56 0.65 0.73 0.75 0.73
Accounts Receivable Turnover		 0.00 6.23 6.09 6.08 0.00 6.23 6.75 7.38 7.94 7.63
Inventory Turnover		 0.00 5.64 5.40 5.44 0.00 5.59 5.76 5.61 5.42 5.06
Fixed Asset Turnover		 0.00 1.95 1.79 1.62 0.00 1.33 1.50 1.76 1.96 1.81
Accounts Payable Turnover		 0.00 3.14 3.04 3.19 0.00 3.16 3.25 4.69 7.56 7.20
Days Sales Outstanding (DSO)		 0.00 58.59 59.97 60.06 0.00 58.63 54.08 49.46 45.99 47.85
Days Inventory Outstanding (DIO)		 0.00 64.76 67.62 67.15 0.00 65.29 63.36 65.02 67.37 72.18
Days Payable Outstanding (DPO)		 0.00 116.25 119.93 114.46 0.00 115.51 112.18 77.80 48.26 50.72
Cash Conversion Cycle (CCC)		 0.00 7.10 7.66 12.74 0.00 8.41 5.26 36.68 65.09 69.32
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 0.00 19,422 22,156 25,584 26,155 25,538 26,300 26,091 25,409 32,322
Invested Capital Turnover		 0.00 2.69 1.25 1.15 0.00 1.00 1.13 1.25 1.36 1.23
Increase / (Decrease) in Invested Capital		 0.00 19,422 2,734 3,428 571 -617 762 -209 -682 6,913
Enterprise Value (EV)		 0.00 0.00 0.00 27,179 38,598 45,909 47,228 32,740 56,643 73,568
Market Capitalization		 0.00 0.00 0.00 19,945 31,471 32,534 41,161 28,805 51,194 62,852
Book Value per Share		 $0.00 $0.00 $20.75 $21.87 $22.56 $15.21 $25.44 $29.22 $27.72 $31.80
Tangible Book Value per Share		 $0.00 $0.00 $10.42 $10.36 $11.33 $3.49 $13.06 $15.65 $14.16 $13.74
Total Capital		 0.00 23,388 27,571 36,123 36,854 33,901 32,775 32,676 33,263 36,818
Total Debt		 0.00 8,195 9,581 17,172 17,220 13,554 11,861 9,636 11,642 13,968
Total Long-Term Debt		 0.00 7,906 9,202 9,959 10,604 12,297 11,312 8,145 9,776 10,969
Net Debt		 0.00 4,228 5,501 6,632 6,520 5,190 5,386 3,051 4,681 9,472
Capital Expenditures (CapEx)		 958 897 1,254 1,324 1,374 996 1,167 1,408 1,713 2,306
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 882 2,019 1,394 538 1,031 1,190 2,347 2,397 3,027
Debt-free Net Working Capital (DFNWC)		 0.00 3,482 4,601 10,602 10,463 8,769 7,012 8,283 8,738 6,786
Net Working Capital (NWC)		 0.00 3,193 4,221 3,389 3,847 7,512 6,463 6,792 6,872 3,787
Net Nonoperating Expense (NNE)		 95 137 -6.88 -1,016 -1,738 241 -56 -919 149 270
Net Nonoperating Obligations (NNO)		 0.00 4,229 4,166 6,633 6,521 5,191 5,386 3,051 3,788 9,472
Total Depreciation and Amortization (D&A)		 916 1,061 1,208 1,265 1,787 1,624 1,551 1,577 1,633 1,798
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 3.38% 7.76% 5.08% 0.00% 3.98% 4.07% 7.17% 6.86% 8.51%
Debt-free Net Working Capital to Revenue		 0.00% 13.35% 17.69% 38.66% 0.00% 33.87% 24.01% 25.31% 25.00% 19.08%
Net Working Capital to Revenue		 0.00% 12.24% 16.23% 12.36% 0.00% 29.02% 22.13% 20.76% 19.66% 10.65%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $2.27 $3.02 $2.41 $142.90 $0.00 $5.07 $4.36 $5.06
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 838.96M 843.39M 799.64M 795.14M 0.00 752.14M 723.90M 683.30M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $2.25 $3.01 $2.39 $141.80 $0.00 $5.03 $4.33 $5.02
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 838.96M 843.39M 799.64M 795.14M 0.00 752.14M 729.20M 689.50M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 838.96M 843.39M 799.64M 795.14M 0.00 752.14M 690.36M 676.48M
Normalized Net Operating Profit after Tax (NOPAT)		 887 1,473 2,298 1,873 0.00 1,406 2,600 2,931 3,445 3,733
Normalized NOPAT Margin		 3.81% 5.65% 8.84% 6.83% 0.00% 5.43% 8.90% 8.96% 9.86% 10.49%
Pre Tax Income Margin		 4.30% 6.54% 7.78% 7.27% 0.00% 5.62% 10.62% 10.58% 11.49% 13.25%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 3.05 4.99 6.38 0.00 0.00 4.28 10.85 10.87 11.13 8.47
NOPAT to Interest Expense		 2.06 3.58 6.36 0.00 0.00 3.21 8.35 8.63 8.57 6.20
EBIT Less CapEx to Interest Expense		 0.83 2.81 2.91 0.00 0.00 2.01 7.14 6.78 6.57 4.70
NOPAT Less CapEx to Interest Expense		 -0.17 1.40 2.89 0.00 0.00 0.94 4.64 4.54 4.01 2.43
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 52.54% 28.35% 24.86% 21.91% 38.15% 61.97% 35.22% 24.25% 31.74% 49.42%
Augmented Payout Ratio		 52.54% 28.35% 25.01% 53.79% 93.04% 83.35% 68.58% 54.54% 131.58% 91.51%

Quarterly Metrics And Ratios for CRH

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 1.65% -0.57% 3.82% 2.13% 3.41%
EBITDA Growth		 0.00% 0.00% 0.00% 0.00% 51.81% 12.90% 13.78% 32.84% -18.94%
EBIT Growth		 0.00% 0.00% 0.00% 0.00% 9,350.00% 14.67% 13.25% 43.44% -101.06%
NOPAT Growth		 0.00% 0.00% 0.00% 0.00% 2,283.84% 12.21% 4.29% 48.98% -62.25%
Net Income Growth		 0.00% 0.00% 0.00% 0.00% 467.74% 8.00% 5.39% 23.73% -185.96%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 420.00% 16.05% 9.44% 5.21% -193.75%
Operating Cash Flow Growth		 0.00% 0.00% 0.00% 0.00% -6.11% -9.12% -8.89% 12.67% 7.44%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -78.03%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 9.87% 9.40% 19.49% 27.21% 15.83%
Revenue Q/Q Growth		 0.00% 51.07% 4.32% -14.25% 0.00% 47.77% 8.92% -15.64% -23.83%
EBITDA Q/Q Growth		 0.00% 422.28% 8.68% -44.14% 0.00% 288.40% 9.53% -34.78% -70.79%
EBIT Q/Q Growth		 0.00% 80,650.00% 10.77% -56.51% 0.00% 879.89% 9.40% -44.92% -100.18%
NOPAT Q/Q Growth		 0.00% 87,442.41% 10.60% -53.25% 0.00% 4,020.55% 2.80% -33.22% -98.67%
Net Income Q/Q Growth		 0.00% 4,009.68% 8.75% -56.53% 0.00% 1,048.25% 6.11% -48.96% -113.82%
EPS Q/Q Growth		 0.00% 3,340.00% 11.11% -46.67% 0.00% 1,075.00% 4.79% -48.73% -114.85%
Operating Cash Flow Q/Q Growth		 0.00% 343.52% -0.18% 48.56% 0.00% 308.57% 0.07% 83.71% -124.14%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 53.37% -228.21% -50.07% 22.49%
Invested Capital Q/Q Growth		 0.00% 3.14% 0.53% -8.12% 0.00% 2.70% 9.80% -2.19% 5.02%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 25.19% 37.39% 37.15% 33.98% 27.66% 38.07% 38.60% 35.63% 27.19%
EBITDA Margin		 6.01% 20.76% 21.63% 14.09% 8.97% 23.58% 23.71% 18.33% 7.03%
Operating Margin		 0.03% 16.61% 17.65% 9.02% 0.43% 18.95% 18.68% 12.45% 0.27%
EBIT Margin		 0.03% 16.63% 17.66% 8.96% 2.89% 19.18% 19.27% 12.58% -0.03%
Profit (Net Income) Margin		 -0.48% 12.48% 13.01% 6.60% 1.75% 13.56% 13.21% 7.99% -1.45%
Tax Burden Percent		 79.49% 76.81% 76.63% 75.89% 115.15% 75.53% 73.30% 71.83% 67.12%
Interest Burden Percent		 -1,950.00% 97.71% 96.14% 97.04% 52.38% 93.57% 93.53% 88.44% 7,300.00%
Effective Tax Rate		 0.00% 24.02% 24.19% 19.07% -19.19% 24.81% 28.02% 14.49% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 10.04% 0.64% 17.31% 15.67% 13.12% 0.21%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 8.43% 1.87% 16.32% 15.34% 9.57% -0.89%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 1.48% 0.57% 4.97% 4.99% 2.85% -0.41%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 11.51% 1.21% 22.28% 20.66% 15.97% -0.20%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 15.36% 0.00% 0.00% 0.00% -10.81% -2.76%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 6.75% 2.22% 14.25% 13.79% 9.13% -0.02%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 4.97% 1.34% 10.07% 9.46% 5.80% -1.06%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 11.09% 1.17% 21.47% 19.68% 15.25% -0.19%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 16.07% 15.99% 15.47% 0.00% 15.67%
Net Operating Profit after Tax (NOPAT)		 1.40 1,226 1,356 634 33 1,375 1,414 944 13
NOPAT Margin		 0.02% 12.62% 13.38% 7.30% 0.51% 14.24% 13.44% 10.64% 0.19%
Net Nonoperating Expense Percent (NNEP)		 0.72% 0.28% 0.75% 1.60% -1.23% 0.98% 0.33% 3.55% 1.10%
Return On Investment Capital (ROIC_SIMPLE)		 - - - 1.92% - - - 2.59% 0.03%
Cost of Revenue to Revenue		 74.81% 62.61% 62.85% 66.02% 72.34% 61.93% 61.40% 64.37% 72.81%
SG&A Expenses to Revenue		 25.24% 20.96% 19.65% 21.17% 27.35% 20.18% 20.77% 21.79% 27.13%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 25.16% 20.77% 19.50% 24.96% 27.23% 19.12% 19.92% 23.18% 26.92%
Earnings before Interest and Taxes (EBIT)		 2.00 1,615 1,789 778 189 1,852 2,026 1,116 -2.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 386 2,016 2,191 1,224 586 2,276 2,493 1,626 475
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 1.70 1.83 1.83 2.46 2.98 2.48 2.89 2.91 2.82
Price to Tangible Book Value (P/TBV)		 3.33 3.49 3.57 4.81 6.77 5.48 6.42 6.73 7.06
Price to Revenue (P/Rev)		 0.00 0.00 0.00 1.46 1.70 1.47 1.79 1.77 1.66
Price to Earnings (P/E)		 0.00 0.00 0.00 16.11 17.93 15.05 18.14 18.00 18.13
Dividend Yield		 0.00% 0.00% 0.00% 1.95% 1.95% 2.71% 2.56% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 6.21% 5.58% 6.64% 5.51% 5.56% 5.52%
Enterprise Value to Invested Capital (EV/IC)		 1.56 1.66 1.65 2.23 2.36 2.02 2.25 2.28 2.13
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 1.62 1.97 1.74 2.11 2.07 2.02
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 9.74 11.47 9.70 11.32 10.54 10.53
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 13.54 15.79 13.22 15.38 14.19 14.49
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 17.58 21.06 17.76 21.35 19.40 19.21
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 11.29 13.87 12.62 15.91 14.75 14.35
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 0.44 0.43 0.50 0.54 0.61 0.61 0.60 0.61 0.70
Long-Term Debt to Equity		 0.34 0.33 0.42 0.45 0.47 0.46 0.46 0.48 0.64
Financial Leverage		 0.20 0.21 0.22 0.18 0.31 0.30 0.33 0.30 0.47
Leverage Ratio		 2.04 2.03 2.10 2.08 2.13 2.13 2.16 2.21 2.28
Compound Leverage Factor		 -39.72 1.99 2.02 2.02 1.12 2.00 2.02 1.95 166.42
Debt to Total Capital		 30.75% 30.03% 33.47% 35.00% 37.92% 37.95% 37.48% 37.94% 41.21%
Short-Term Debt to Total Capital		 7.04% 6.73% 5.46% 5.61% 8.95% 9.31% 8.68% 8.15% 3.83%
Long-Term Debt to Total Capital		 23.71% 23.30% 28.01% 29.39% 28.97% 28.64% 28.80% 29.79% 37.38%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 2.78% 2.74% 2.59% 2.31% 2.18% 2.10% 3.48% 3.38% 3.26%
Common Equity to Total Capital		 66.46% 67.23% 63.94% 62.69% 59.90% 59.95% 59.03% 58.68% 55.53%
Debt to EBITDA		 0.00 0.00 0.00 2.00 2.11 2.09 2.11 2.00 2.28
Net Debt to EBITDA		 0.00 0.00 0.00 0.80 1.46 1.39 1.50 1.36 1.69
Long-Term Debt to EBITDA		 0.00 0.00 0.00 1.68 1.61 1.58 1.62 1.57 2.07
Debt to NOPAT		 0.00 0.00 0.00 3.61 3.86 3.82 3.98 3.68 4.16
Net Debt to NOPAT		 0.00 0.00 0.00 1.45 2.67 2.54 2.83 2.50 3.08
Long-Term Debt to NOPAT		 0.00 0.00 0.00 3.03 2.95 2.89 3.06 2.89 3.78
Altman Z-Score		 0.00 0.00 0.00 2.83 2.94 2.80 2.92 2.89 2.66
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 3.70% 3.77% 3.66% 4.75% 4.52% 4.56%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 1.54 1.56 1.78 1.69 1.37 1.43 1.39 1.37 1.63
Quick Ratio		 1.01 1.07 1.27 1.08 0.81 0.85 0.88 0.83 0.97
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.00 0.00 -2,599 -1,212 -3,977 -5,969 -4,626
Operating Cash Flow to CapEx		 -205.83% 405.46% 426.96% 402.49% 0.00% 556.18% 352.97% 147.49% -108.03%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 -19.54 -7.82 -24.25 -37.31 -25.56
Operating Cash Flow to Interest Expense		 -8.28 22.38 12.45 26.63 -5.35 9.58 9.06 17.06 -3.64
Operating Cash Flow Less CapEx to Interest Expense		 -12.31 16.86 9.53 20.01 -3.60 7.86 6.49 5.49 -7.01
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.75 0.77 0.74 0.72 0.73 0.73
Accounts Receivable Turnover		 0.00 0.00 0.00 7.94 7.38 5.83 5.71 7.63 7.20
Inventory Turnover		 0.00 0.00 0.00 5.42 5.05 5.19 5.18 5.06 4.82
Fixed Asset Turnover		 0.00 0.00 0.00 1.96 1.90 1.87 1.80 1.81 1.74
Accounts Payable Turnover		 0.00 0.00 0.00 7.56 8.55 6.59 7.74 7.20 8.38
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 45.99 49.48 62.63 63.92 47.85 50.67
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 67.37 72.33 70.35 70.43 72.18 75.80
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 48.26 42.68 55.35 47.17 50.72 43.58
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 65.09 79.12 77.63 87.18 69.32 82.89
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 26,673 27,510 27,656 25,409 29,305 30,097 33,047 32,322 33,944
Invested Capital Turnover		 0.00 0.00 0.00 1.38 1.25 1.22 1.17 1.23 1.13
Increase / (Decrease) in Invested Capital		 0.00 0.00 0.00 0.00 2,632 2,587 5,391 6,913 4,639
Enterprise Value (EV)		 41,537 45,573 45,711 56,643 69,033 60,912 74,494 73,568 72,336
Market Capitalization		 36,118 39,883 39,821 51,194 59,550 51,487 63,321 62,852 59,510
Book Value per Share		 $28.26 $29.01 $28.94 $27.72 $29.10 $30.18 $32.04 $31.80 $31.22
Tangible Book Value per Share		 $14.43 $15.18 $14.82 $14.16 $12.79 $13.67 $14.45 $13.74 $12.47
Total Capital		 31,978 32,457 34,043 33,263 33,414 34,569 37,056 36,818 38,028
Total Debt		 9,834 9,748 11,395 11,642 12,672 13,118 13,890 13,968 15,671
Total Long-Term Debt		 7,583 7,563 9,535 9,776 9,680 9,900 10,672 10,969 14,213
Net Debt		 4,529 4,801 5,008 4,681 8,755 8,699 9,881 9,472 11,587
Capital Expenditures (CapEx)		 326 403 382 602 -233 267 421 1,851 610
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 2,576 3,313 3,262 2,397 3,396 3,848 4,310 3,027 3,636
Debt-free Net Working Capital (DFNWC)		 7,226 7,588 8,984 8,738 6,704 7,783 7,390 6,786 6,988
Net Working Capital (NWC)		 4,975 5,403 7,124 6,872 3,712 4,565 4,172 3,787 5,530
Net Nonoperating Expense (NNE)		 32 14 38 61 -81 66 25 235 111
Net Nonoperating Obligations (NNO)		 4,529 4,801 5,008 3,788 8,563 8,646 9,881 9,472 11,587
Total Depreciation and Amortization (D&A)		 384 401 402 446 397 424 467 510 477
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 6.86% 9.69% 10.99% 12.18% 8.51% 10.16%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 25.00% 19.12% 22.24% 20.88% 19.08% 19.52%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 19.66% 10.59% 13.04% 11.79% 10.65% 15.45%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.97 $0.16 $1.89 $1.99 $1.02 ($0.15)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 723.90M 687.80M 685.50M 681.60M 683.30M 676.70M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.96 $0.16 $1.88 $1.97 $1.01 ($0.15)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 729.20M 693.40M 688.80M 685.50M 689.50M 676.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 690.36M 686.68M 682.78M 679.34M 676.48M 676.00M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.10 1,212 1,344 611 14 1,298 1,350 912 2.80
Normalized NOPAT Margin		 -0.03% 12.48% 13.27% 7.04% 0.21% 13.45% 12.84% 10.28% 0.04%
Pre Tax Income Margin		 -0.61% 16.25% 16.98% 8.69% 1.52% 17.95% 18.02% 11.13% -2.16%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 0.02 22.12 13.66 8.55 1.42 11.95 12.35 6.98 -0.01
NOPAT to Interest Expense		 0.02 16.79 10.35 6.96 0.25 8.87 8.62 5.90 0.07
EBIT Less CapEx to Interest Expense		 -4.00 16.60 10.74 1.93 3.17 10.23 9.79 -4.59 -3.38
NOPAT Less CapEx to Interest Expense		 -4.01 11.27 7.43 0.35 2.00 7.15 6.05 -5.67 -3.30
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 31.74% 53.81% 43.63% 49.72% 49.42% 29.92%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 131.58% 158.87% 134.61% 116.48% 91.51% 67.18%

Key Financial Trends

CRH (NYSE: CRH) experienced a notable downturn in its Q1 2025 financial results compared to the previous quarters of 2023 and 2024, as well as the earlier part of 2025. Here are the key highlights and trends observed from the last four years of data:

  • Q1 2025 saw a net loss of $98 million, a sharp reversal from profitable quarters with net income ranging from about $114 million to over $1.3 billion in prior periods.
  • Operating Revenue declined sharply to $6.76 billion in Q1 2025 from $8.87 billion in Q4 2024 and above $10 billion in 2024 quarters, indicating weakening sales or lower volumes/prices.
  • Operating income was close to zero ($18 million) in Q1 2025, dramatically down from Q4 2024 ($1.1 billion) and prior quarters above $1.6 billion, signaling margin pressure or rising costs.
  • Negative cash flow from operating activities of $659 million in Q1 2025 contrasts with positive operating cash flow in previous quarters, raising concerns about operational efficiency.
  • Acquisitions and CapEx remain high in Q1 2025 ($645M CapEx, $585M acquisitions), further pressuring free cash flow amid earnings weakness.
  • Strong gross profit margin at about 27% in Q1 2025 ($1.84B gross profit on $6.76B revenue) remains fairly stable over recent quarters, suggesting cost of goods sold is controlled.
  • Solid common equity base increased to $21.1 billion as of Q1 2025, up slightly from prior quarters, bolstering the company’s capital structure.
  • Debt levels remain elevated, with $14.2 billion long-term and $1.46 billion short-term debt at Q1 2025, similar to prior quarters, reflecting ongoing leverage to fund operations and acquisitions.
  • Dividends remain steady around 35-37 cents per share per quarter, indicating management's commitment to shareholder returns despite earnings volatility.
  • Interest expenses increased slightly in Q1 2025 ($181 million) compared to previous quarters, adding pressure to net income.

Summary: CRH has faced a challenging start to 2025 with diminished revenues and earnings translating into a quarterly loss, contrasting with steady profitability in 2023 and 2024. Elevated acquisition and capital spending combined with weakening operating cash flow create headwinds for free cash generation. However, the company maintains a solid equity base and continues to pay dividends. Investors should watch upcoming quarters for signs of revenue recovery and cost management improvements that may restore profitability and cash flow.

08/05/25 02:40 PMAI Generated. May Contain Errors.

Frequently Asked Questions About CRH's Financials

When does CRH's fiscal year end?

According to the most recent income statement we have on file, CRH's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has CRH's net income changed over the last 9 years?

CRH's net income appears to be on an upward trend, with a most recent value of $3.52 billion in 2024, rising from $792.09 million in 2015. The previous period was $3.07 billion in 2023. View CRH's forecast to see where analysts expect CRH to go next.

What is CRH's operating income?
CRH's total operating income in 2024 was $4.93 billion, based on the following breakdown:
  • Total Gross Profit: $12.70 billion
  • Total Operating Expenses: $7.78 billion
How has CRH's revenue changed over the last 9 years?

Over the last 9 years, CRH's total revenue changed from $23.26 billion in 2015 to $35.57 billion in 2024, a change of 52.9%.

How much debt does CRH have?

CRH's total liabilities were at $27.76 billion at the end of 2024, a 7.4% increase from 2023, and a 53.9% increase since 2016.

How much cash does CRH have?

In the past 8 years, CRH's cash and equivalents has ranged from $2.54 billion in 2017 to $9.92 billion in 2019, and is currently $3.72 billion as of their latest financial filing in 2024.

How has CRH's book value per share changed over the last 9 years?

Over the last 9 years, CRH's book value per share changed from 0.00 in 2015 to 31.80 in 2024, a change of 3,180.5%.


Related Companies

This page (NYSE:CRH) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Crypto 101 Media | Sponsored
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsored
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsored
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsored
Wall Street Hates This Gold IRA Strategy—Here’s Why
What if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...
Advantage Gold | Sponsored
Digital Dollar Alert: Protect Your Wealth Before It’s Too Late
134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...
American Alternative | Sponsored
One stock to replace Nvidia
I'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...
InvestorPlace | Sponsored
Washington Thinks They Own Your Bank Account
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...
Priority Gold | Sponsored